Literature DB >> 36267932

Inflammatory Markers in the Serum and Bronchoalveolar Lavage in Children with Non-Cystic Fibrosis Bronchiectasis.

Hosseinali Ghaffaripour1, Amir Rezaei1, Maryam Hasanzad1, Habib Emami1, Esmaeil Mortaz2,3, Alireza Mahdaviani1, Ali Akbar Velayati1.   

Abstract

Background: It is known that inflammatory responses occur in the airways of patients with non-cystic fibrosis bronchiectasis during respiratory exacerbations but the role of these cytokines is not clear in this condition. Herein we evaluated the levels of interleukin-1β (IL-1β), IL-8 and tumor necrosis factor α (TNF-α) in the serum and bronchoalveolar lavage among children with non-cystic fibrosis bronchiectasis. Materials and
Methods: This cross-sectional study was performed on all children with non-cystic fibrosis bronchiectasis who were admitted with respiratory exacerbation in the pediatric pulmonology ward of Masih Daneshvari Hospital, Tehran-Iran. All patients underwent fiberoptic bronchoscopy and spirometry before and after the bronchoscopy. IL-1β, IL-8, and TNF-α levels were measured in the serum and bronchoalveolar lavage.
Results: Patients included 10 (59%) female and 7 (41%) male subjects with mean age of 13.8 years (range, 5-18). Mean values for forced vital capacity (FVC) and forced expiratory volume in one second (FEV1) were below the normal range before and after bronchoscopy. Mean value for FVC (from 55% to 63%, P= 0.01) and FEV1 (from 60% to 64%, P= 0.26) increased after bronchoscopy compared to before that. IL-1β and IL-8 levels were increased and TNF-α level was decreased in the serum and bronchoalveolar lavage but no significant correlation was found between spirometry and these cytokines levels.
Conclusion: Changes in inflammatory cytokines levels in serum and bronchoalveolar lavage during respiratory exacerbation in patients with noncystic fibrosis bronchiectasis have no significant correlation with spirometry and cannot be used in clinical practice. Copyright
© 2021 National Research Institute of Tuberculosis and Lung Disease.

Entities:  

Keywords:  Bronchoalveolar lavage; Inflammatory cytokine; Non-cystic fibrosis bronchiectasis; Serum

Year:  2021        PMID: 36267932      PMCID: PMC9577213     

Source DB:  PubMed          Journal:  Tanaffos        ISSN: 1735-0344


  23 in total

1.  Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients.

Authors:  M S Muhlebach; P W Stewart; M W Leigh; T L Noah
Journal:  Am J Respir Crit Care Med       Date:  1999-07       Impact factor: 21.405

2.  Human neutrophil elastase-mediated cleavage sites of MMP-9 and TIMP-1: implications to cystic fibrosis proteolytic dysfunction.

Authors:  Patricia L Jackson; Xin Xu; Landon Wilson; Nathaniel M Weathington; John Paul Clancy; James Edwin Blalock; Amit Gaggar
Journal:  Mol Med       Date:  2010-01-22       Impact factor: 6.354

3.  IL-8 dictates glycosaminoglycan binding and stability of IL-18 in cystic fibrosis.

Authors:  Emer P Reeves; Michael Williamson; Barry Byrne; David A Bergin; Stephen G J Smith; Peter Greally; Richard O'Kennedy; Shane J O'Neill; Noel G McElvaney
Journal:  J Immunol       Date:  2009-12-21       Impact factor: 5.422

4.  Association between inflammatory markers in induced sputum and clinical characteristics in children with non-cystic fibrosis bronchiectasis.

Authors:  Tulay Guran; Refika Ersu; Bulent Karadag; Ihsan Nuri Akpinar; Gulderen Yanikkaya Demirel; Nezih Hekim; Elif Dagli
Journal:  Pediatr Pulmonol       Date:  2007-04

5.  Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis.

Authors:  Miguel Angel Martínez-García; Juan-Jose Soler-Cataluña; Miguel Perpiñá-Tordera; Pilar Román-Sánchez; Joan Soriano
Journal:  Chest       Date:  2007-11       Impact factor: 9.410

6.  Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial.

Authors:  Lisa Saiman; Bruce C Marshall; Nicole Mayer-Hamblett; Jane L Burns; Alexandra L Quittner; Debra A Cibene; Sarah Coquillette; Ann Yunker Fieberg; Frank J Accurso; Preston W Campbell
Journal:  JAMA       Date:  2003-10-01       Impact factor: 56.272

7.  Human neutrophil collagenase (MMP-8), identified in bronchiectasis BAL fluid, correlates with severity of disease.

Authors:  R Sepper; Y T Konttinen; Y Ding; M Takagi; T Sorsa
Journal:  Chest       Date:  1995-06       Impact factor: 9.410

Review 8.  Bronchiectasis in Children: Current Concepts in Immunology and Microbiology.

Authors:  Susan J Pizzutto; Kim M Hare; John W Upham
Journal:  Front Pediatr       Date:  2017-05-29       Impact factor: 3.418

9.  Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis.

Authors:  David A Bergin; Killian Hurley; Adwait Mehta; Stephen Cox; Dorothy Ryan; Shane J O'Neill; Emer P Reeves; Noel G McElvaney
Journal:  J Inflamm Res       Date:  2013-01-23

Review 10.  The role of macrolides in childhood non-cystic fibrosis-related bronchiectasis.

Authors:  R Masekela; R J Green
Journal:  Mediators Inflamm       Date:  2012-04-18       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.